Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis
Abstract Baseline IL-6 levels have been found to be non-predictive of subsequent outcomes following tocilizumab treatment, highlighting the need for more reliable predictive markers. To address this, a retrospective analysis was conducted on the clinical profiles, diagnostic tests, and follow-up pro...
Saved in:
| Main Authors: | Panpan Liang, Yan Li, Li’e Meng, Yuting Li, Hailing Mai, Tao Li, Jiarui Ma, Junhui Ma, Jing Wang, Bing Zhuan, Wei Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-81028-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A spectacular effect of tocilizumab in Takayasu arteritis
by: Fatma Saïd, et al.
Published: (2024-11-01) -
Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope
by: Jin Guo, et al.
Published: (2024-12-01) -
Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation
by: Ping Chen, et al.
Published: (2024-12-01) -
Efficacy of Tocilizumab in Patients with a Moderate and Severe COVID-19: A Retrospective Single Center Cohort Study
by: Sibel BOLUKÇU, et al.
Published: (2021-01-01) -
Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study
by: Jie Gao, et al.
Published: (2025-07-01)